Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	mRNA CDS binding	HNRNPK HNRNPL	3.54e-05	8	23	2	GO:1990715
GeneOntologyMolecularFunction	mRNA binding	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	9.99e-04	694	23	5	GO:0003729
GeneOntologyMolecularFunction	pre-mRNA binding	HNRNPK HNRNPL	2.45e-03	64	23	2	GO:0036002
GeneOntologyMolecularFunction	mRNA 3'-UTR binding	HNRNPK HNRNPL HNRNPR	3.77e-03	276	23	3	GO:0003730
GeneOntologyBiologicalProcess	mRNA processing	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	2.41e-04	551	22	5	GO:0006397
GeneOntologyBiologicalProcess	regulation of mRNA splicing, via spliceosome	RBMX HNRNPK HNRNPL	3.37e-04	129	22	3	GO:0048024
GeneOntologyBiologicalProcess	negative regulation of mRNA splicing, via spliceosome	RBMX HNRNPK	4.04e-04	28	22	2	GO:0048025
GeneOntologyBiologicalProcess	negative regulation of mRNA processing	RBMX HNRNPK	4.33e-04	29	22	2	GO:0050686
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	RBMX HNRNPK HNRNPL HNRNPR	5.10e-04	358	22	4	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	RBMX HNRNPK HNRNPL HNRNPR	5.10e-04	358	22	4	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	RBMX HNRNPK HNRNPL HNRNPR	5.31e-04	362	22	4	GO:0000375
GeneOntologyBiologicalProcess	negative regulation of RNA splicing	RBMX HNRNPK	5.62e-04	33	22	2	GO:0033119
GeneOntologyBiologicalProcess	regulation of mRNA processing	RBMX HNRNPK HNRNPL	6.10e-04	158	22	3	GO:0050684
GeneOntologyBiologicalProcess	vesicle cargo loading	SEC24D MIA2	6.69e-04	36	22	2	GO:0035459
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	RBMX HNRNPK HNRNPL HNRNPR	1.13e-03	443	22	4	GO:1903311
GeneOntologyBiologicalProcess	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	CDIP1 HNRNPK	1.24e-03	49	22	2	GO:0042771
GeneOntologyBiologicalProcess	regulation of RNA splicing	RBMX HNRNPK HNRNPL	1.33e-03	207	22	3	GO:0043484
GeneOntologyCellularComponent	beta-catenin-TCF complex	TCF4 BCL9	8.97e-05	13	23	2	GO:1990907
GeneOntologyCellularComponent	catalytic step 2 spliceosome	RBMX HNRNPK HNRNPR	1.60e-04	97	23	3	GO:0071013
GeneOntologyCellularComponent	nuclear protein-containing complex	SMARCD1 CPSF6 TCF4 RBMX HNRNPK HNRNPR BCL9	5.09e-04	1377	23	7	GO:0140513
GeneOntologyCellularComponent	chromatin	SMARCD1 CPSF6 TCF4 RBMX HNRNPK HNRNPL BHLHA9	7.86e-04	1480	23	7	GO:0000785
GeneOntologyCellularComponent	endoplasmic reticulum exit site	SEC24D MIA2	9.71e-04	42	23	2	GO:0070971
GeneOntologyCellularComponent	spliceosomal complex	RBMX HNRNPK HNRNPR	1.63e-03	215	23	3	GO:0005681
HumanPheno	Intellectual disability, moderate	SMARCD1 TCF4 RBMX HNRNPK	4.06e-05	172	7	4	HP:0002342
Domain	RRM_1	CPSF6 RBMX HNRNPL HNRNPR	1.33e-04	208	24	4	PF00076
Domain	RRM	CPSF6 RBMX HNRNPL HNRNPR	1.57e-04	217	24	4	SM00360
Domain	RRM_dom	CPSF6 RBMX HNRNPL HNRNPR	1.87e-04	227	24	4	IPR000504
Domain	RRM	CPSF6 RBMX HNRNPL HNRNPR	1.96e-04	230	24	4	PS50102
Domain	-	CPSF6 RBMX HNRNPL HNRNPR	2.46e-04	244	24	4	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	CPSF6 RBMX HNRNPL HNRNPR	3.04e-04	258	24	4	IPR012677
Domain	SH3_2	MYO15B MIA2	5.42e-03	86	24	2	IPR011511
Domain	SH3_2	MYO15B MIA2	5.42e-03	86	24	2	PF07653
Domain	-	TCF4 BHLHA9	8.57e-03	109	24	2	4.10.280.10
Domain	HLH	TCF4 BHLHA9	8.87e-03	111	24	2	PF00010
Domain	HLH	TCF4 BHLHA9	9.65e-03	116	24	2	SM00353
Domain	BHLH	TCF4 BHLHA9	9.81e-03	117	24	2	PS50888
Domain	bHLH_dom	TCF4 BHLHA9	9.98e-03	118	24	2	IPR011598
Domain	SH3_domain	MYO15B MIA2	3.22e-02	220	24	2	IPR001452
Pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	4.89e-06	277	14	5	MM15414
Pathway	REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	5.43e-06	283	14	5	M13087
Pathway	WP_MRNA_PROCESSING	RBMX HNRNPK HNRNPL HNRNPR	5.68e-06	126	14	4	M39406
Pathway	REACTOME_MRNA_SPLICING	RBMX HNRNPK HNRNPL HNRNPR	3.59e-05	201	14	4	MM15411
Pathway	REACTOME_MRNA_SPLICING	RBMX HNRNPK HNRNPL HNRNPR	4.42e-05	212	14	4	M14033
Pathway	REACTOME_METABOLISM_OF_RNA	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	2.19e-04	612	14	5	MM15547
Pathway	REACTOME_CARGO_CONCENTRATION_IN_THE_ER	SEC24D MIA2	4.75e-04	33	14	2	M27591
Pathway	REACTOME_METABOLISM_OF_RNA	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	4.78e-04	724	14	5	M16843
Pathway	REACTOME_CARGO_CONCENTRATION_IN_THE_ER	SEC24D MIA2	5.66e-04	36	14	2	MM15300
Pathway	WP_MRNA_PROCESSING	RBMX HNRNPK HNRNPL HNRNPR	8.02e-04	451	14	4	MM15946
Pathway	WP_WNT_SIGNALING_WP363	TCF4 BCL9	1.14e-03	51	14	2	M39721
Pathway	PID_BETA_CATENIN_NUC_PATHWAY	TCF4 BCL9	2.77e-03	80	14	2	M223
Pathway	REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX	TCF4 BCL9	3.57e-03	91	14	2	M27101
Pubmed	Characterizing WW domain interactions of tumor suppressor WWOX reveals its association with multiprotein networks.	WIPF2 CPSF6 PRRC2A RBMX YLPM1 HNRNPR BCL9	1.16e-10	220	24	7	24550385
Pubmed	HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137.	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	6.78e-10	148	24	6	32538781
Pubmed	DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation.	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	4.01e-09	89	24	5	22446626
Pubmed	Intersectin (ITSN) family of scaffolds function as molecular hubs in protein interaction networks.	WIPF2 CPSF6 RBMX HNRNPK YLPM1	1.22e-08	111	24	5	22558309
Pubmed	Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing.	RBMX HNRNPK HNRNPL HNRNPR	1.57e-08	40	24	4	23825951
Pubmed	Identification of DeltaNp63alpha protein interactions by mass spectrometry.	CPSF6 HNRNPK HNRNPL HNRNPR	3.32e-08	48	24	4	20085233
Pubmed	Interactome analysis of the human Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (hMTr1) protein.	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	3.66e-08	138	24	5	30320910
Pubmed	Next-generation sequencing to generate interactome datasets.	SMARCD1 CDIP1 MAPK1IP1L SEC24D SSBP2 RBMX HNRNPK MYO15B MIA2	3.74e-08	1147	24	9	21516116
Pubmed	WW domains provide a platform for the assembly of multiprotein networks.	WIPF2 CPSF6 HNRNPK HNRNPL YLPM1	6.33e-08	154	24	5	16055720
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	SMARCD1 CPSF6 PRRC2A RBMX HNRNPK HNRNPL HNRNPR	1.39e-07	615	24	7	31048545
Pubmed	A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons.	RBMX HNRNPK HNRNPR	1.95e-07	17	24	3	12388589
Pubmed	Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	3.40e-07	421	24	6	34650049
Pubmed	Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.	RBMX HNRNPK HNRNPL HNRNPR	3.91e-07	88	24	4	26318153
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SMARCD1 CPSF6 SSBP2 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	4.04e-07	1082	24	8	38697112
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	SMARCD1 CPSF6 PRRC2A RBMX HNRNPK HNRNPL HNRNPR BCL9	4.67e-07	1103	24	8	34189442
Pubmed	The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	5.61e-07	239	24	5	26641092
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	PRRC2A RBMX HNRNPK HNRNPL HNRNPR	6.22e-07	244	24	5	29884807
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	PRRC2A RBMX HNRNPK HNRNPL HNRNPR	8.19e-07	258	24	5	37794589
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	CPSF6 PRRC2A RBMX HNRNPK HNRNPL YLPM1 HNRNPR	8.65e-07	807	24	7	22681889
Pubmed	Comprehensive proteomic analysis of the human spliceosome.	RBMX HNRNPK HNRNPL HNRNPR	9.24e-07	109	24	4	12226669
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	SMARCD1 CPSF6 SSBP2 YLPM1 BCL9	9.87e-07	268	24	5	33640491
Pubmed	FCH domain only-2 organizes clathrin-coated structures and interacts with Disabled-2 for low-density lipoprotein receptor endocytosis.	CPSF6 HNRNPL YLPM1	1.28e-06	31	24	3	22323290
Pubmed	Identification of hnRNPs K, L and A2/B1 as candidate proteins involved in the nutritional regulation of mRNA splicing.	HNRNPK HNRNPL	1.37e-06	3	24	2	17095106
Pubmed	Proteomic analysis of complexes formed by human topoisomerase I.	HNRNPK HNRNPL HNRNPR	1.41e-06	32	24	3	15848144
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	CPSF6 PRRC2A RBMX HNRNPK HNRNPL HNRNPR	1.63e-06	551	24	6	34728620
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	CPSF6 RBMX HNRNPK MYO15B YLPM1 HNRNPR	2.23e-06	582	24	6	20467437
Pubmed	Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.	RBMX HNRNPK HNRNPL HNRNPR	2.24e-06	136	24	4	26979993
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	CPSF6 PRRC2A RBMX HNRNPK HNRNPL YLPM1 HNRNPR	2.63e-06	954	24	7	36373674
Pubmed	circZNF827 nucleates a transcription inhibitory complex to balance neuronal differentiation.	HNRNPK HNRNPL	2.74e-06	4	24	2	33174841
Pubmed	Alternative 3'-end processing of long noncoding RNA initiates construction of nuclear paraspeckles.	CPSF6 HNRNPK	2.74e-06	4	24	2	22960638
Pubmed	Mutations affecting the BHLHA9 DNA-binding domain cause MSSD, mesoaxial synostotic syndactyly with phalangeal reduction, Malik-Percin type.	TCF4 BHLHA9	2.74e-06	4	24	2	25466284
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	SMARCD1 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	2.79e-06	605	24	6	28977666
Pubmed	Human transcription factor protein interaction networks.	SMARCD1 PRRC2A TCF4 SSBP2 HNRNPL YLPM1 HNRNPR BCL9	3.25e-06	1429	24	8	35140242
Pubmed	Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress.	RBMX HNRNPK HNRNPL HNRNPR	4.16e-06	159	24	4	22751105
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	4.32e-06	653	24	6	33742100
Pubmed	A protein-RNA interaction atlas of the ribosome biogenesis factor AATF.	PRRC2A HNRNPL YLPM1 HNRNPR	4.48e-06	162	24	4	31363146
Pubmed	EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3.	PRRC2A RBMX HNRNPK HNRNPR	5.95e-06	174	24	4	35031058
Pubmed	Integrative genomics positions MKRN1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network.	CPSF6 RBMX HNRNPL	6.24e-06	52	24	3	26265008
Pubmed	Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion.	SMARCD1 CPSF6 RBMX HNRNPK HNRNPL HNRNPR	6.64e-06	704	24	6	32994395
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	CPSF6 RBMX YLPM1 BCL9	6.80e-06	180	24	4	35198878
Pubmed	Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm.	HNRNPK HNRNPL	6.83e-06	6	24	2	10772858
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	CPSF6 PRRC2A RBMX HNRNPK HNRNPL HNRNPR	7.03e-06	711	24	6	33022573
Pubmed	Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event.	SMARCD1 PRRC2A HNRNPK HNRNPL	7.10e-06	182	24	4	26527279
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	CPSF6 PRRC2A RBMX HNRNPK HNRNPL HNRNPR	7.14e-06	713	24	6	29802200
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	CPSF6 PRRC2A RBMX HNRNPK HNRNPL HNRNPR	7.20e-06	714	24	6	28302793
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	CPSF6 PRRC2A RBMX HNRNPK HNRNPL HNRNPR	7.85e-06	725	24	6	27025967
Pubmed	The STAR/GSG family protein rSLM-2 regulates the selection of alternative splice sites.	RBMX HNRNPL	9.56e-06	7	24	2	11118435
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	PRRC2A RBMX HNRNPK HNRNPL HNRNPR	1.12e-05	441	24	5	31239290
Pubmed	Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein.	HNRNPK HNRNPR	1.27e-05	8	24	2	19808671
Pubmed	Interaction of two multifunctional proteins. Heterogeneous nuclear ribonucleoprotein K and Y-box-binding protein.	HNRNPK HNRNPL	1.27e-05	8	24	2	10809782
Pubmed	Identification of methylated proteins by protein arginine N-methyltransferase 1, PRMT1, with a new expression cloning strategy.	HNRNPK HNRNPR	1.27e-05	8	24	2	12183049
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	SMARCD1 HNRNPL YLPM1 HNRNPR	1.50e-05	220	24	4	35785414
Pubmed	The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase.	RBMX HNRNPK HNRNPL HNRNPR	1.50e-05	220	24	4	34091597
Pubmed	T-STAR/ETOILE: a novel relative of SAM68 that interacts with an RNA-binding protein implicated in spermatogenesis.	RBMX HNRNPK	2.05e-05	10	24	2	10332027
Pubmed	Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.	RBMX HNRNPK HNRNPL HNRNPR	2.25e-05	244	24	4	30349055
Pubmed	SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.	CPSF6 HNRNPK HNRNPL HNRNPR	2.29e-05	245	24	4	35652658
Pubmed	Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.	RBMX HNRNPK HNRNPR	2.29e-05	80	24	3	11991638
Pubmed	Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon.	RBMX HNRNPK HNRNPL	2.38e-05	81	24	3	26990986
Pubmed	Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex.	HNRNPK HNRNPL	2.50e-05	11	24	2	21900255
Pubmed	A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis.	CPSF6 HNRNPK HNRNPL HNRNPR	2.63e-05	254	24	4	28431233
Pubmed	Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.	RBMX HNRNPK HNRNPL HNRNPR	2.88e-05	260	24	4	36199071
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	CPSF6 PRRC2A RBMX HNRNPL YLPM1 HNRNPR	3.05e-05	922	24	6	27609421
Pubmed	Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.	RBMX HNRNPL HNRNPR	3.26e-05	90	24	3	23151878
Pubmed	Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.	SMARCD1 HNRNPL HNRNPR	3.26e-05	90	24	3	33087562
Pubmed	Cullin-3/KCTD10 complex is essential for K27-polyubiquitination of EIF3D in human hepatocellular carcinoma HepG2 cells.	CPSF6 HNRNPL HNRNPR	3.26e-05	90	24	3	31280863
Pubmed	OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.	SMARCD1 CPSF6 HNRNPK	3.37e-05	91	24	3	30472188
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	CPSF6 HNRNPK HNRNPL HNRNPR	3.39e-05	271	24	4	32433965
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	CPSF6 PRRC2A RBMX HNRNPK HNRNPL HNRNPR MIA2	3.42e-05	1415	24	7	28515276
Pubmed	SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.	PRRC2A RBMX HNRNPK HNRNPL HNRNPR	3.45e-05	558	24	5	27591049
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	PRRC2A HNRNPK HNRNPL HNRNPR	3.54e-05	274	24	4	34244482
Pubmed	RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing.	RBMX HNRNPK	3.54e-05	13	24	2	10749975
Pubmed	Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations.	HNRNPK HNRNPL HNRNPR	3.95e-05	96	24	3	25948554
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	CPSF6 PRRC2A RBMX HNRNPK HNRNPL HNRNPR	4.08e-05	971	24	6	33306668
Pubmed	Proteomic dissection of the von Hippel-Lindau (VHL) interactome.	HNRNPK HNRNPL HNRNPR	4.21e-05	98	24	3	21942715
Pubmed	MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer.	RBMX HNRNPK HNRNPL HNRNPR	4.24e-05	287	24	4	36180891
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	4.52e-05	989	24	6	36424410
Pubmed	Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.	CPSF6 RBMX HNRNPK	4.74e-05	102	24	3	31623628
Pubmed	Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing.	RBMX HNRNPK	5.44e-05	16	24	2	16230076
Pubmed	Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA.	HNRNPK HNRNPL HNRNPR	5.47e-05	107	24	3	32989256
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	5.48e-05	1024	24	6	24711643
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	WIPF2 PRRC2A HNRNPK	5.62e-05	108	24	3	19531213
Pubmed	Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy.	RBMX HNRNPK HNRNPR	5.78e-05	109	24	3	29511296
Pubmed	The DNA sequence and analysis of human chromosome 14.	MAPK1IP1L YLPM1 MIA2	6.10e-05	111	24	3	12508121
Pubmed	A comprehensive family-based replication study of schizophrenia genes.	PRRC2A TCF4	6.17e-05	17	24	2	23894747
Pubmed	LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization.	PRRC2A RBMX	6.17e-05	17	24	2	37072811
Pubmed	Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes.	RBMX HNRNPK HNRNPR	6.78e-05	115	24	3	17332742
Pubmed	TIF1gamma controls erythroid cell fate by regulating transcription elongation.	TCF4 SSBP2	6.94e-05	18	24	2	20603019
Pubmed	Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1.	HNRNPK HNRNPL HNRNPR	6.95e-05	116	24	3	21549307
Pubmed	SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.	PRRC2A HNRNPK HNRNPL YLPM1 HNRNPR	7.37e-05	655	24	5	35819319
Pubmed	NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90.	RBMX HNRNPK HNRNPL HNRNPR	7.54e-05	333	24	4	32665550
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	PRRC2A HNRNPK HNRNPL HNRNPR	8.17e-05	340	24	4	24332808
Pubmed	Interactome of Aiolos/Ikaros Reveals Combination Rationale of Cereblon Modulators with HDAC Inhibitors in DLBCL.	RBMX HNRNPK HNRNPL	8.27e-05	123	24	3	35583604
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	HNRNPK HNRNPL HNRNPR	8.48e-05	124	24	3	20850016
Pubmed	ETO2 coordinates cellular proliferation and differentiation during erythropoiesis.	TCF4 SSBP2	8.61e-05	20	24	2	16407974
Pubmed	PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.	CPSF6 PRRC2A RBMX HNRNPL HNRNPR	8.67e-05	678	24	5	30209976
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	RBMX HNRNPK HNRNPL HNRNPR	8.84e-05	347	24	4	16033648
Pubmed	The DNA Methyltransferase 1 (DNMT1) Controls the Shape and Dynamics of Migrating POA-Derived Interneurons Fated for the Murine Cerebral Cortex.	ZIC4 TCF4	9.51e-05	21	24	2	29117290
Pubmed	Enhancer recruitment of transcription repressors RUNX1 and TLE3 by mis-expressed FOXC1 blocks differentiation in acute myeloid leukemia.	RBMX HNRNPL HNRNPR	9.98e-05	131	24	3	34551306
Pubmed	Intrinsically Disordered Protein TEX264 Mediates ER-phagy.	PRRC2A RBMX HNRNPR	9.98e-05	131	24	3	31006538
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	WIPF2 PRRC2A RBMX HNRNPK	1.02e-04	360	24	4	33111431
Interaction	NCK2 interactions	WIPF2 CPSF6 PRRC2A TCF4 HNRNPK HNRNPL YLPM1	1.19e-08	262	23	7	int:NCK2
Interaction	WWOX interactions	WIPF2 CPSF6 PRRC2A RBMX HNRNPK HNRNPL YLPM1 HNRNPR BCL9	1.43e-08	627	23	9	int:WWOX
Interaction	EWSR1 interactions	CPSF6 PRRC2A MAPK1IP1L SEC24D SSBP2 RBMX HNRNPK HNRNPL HNRNPR BCL9	2.15e-08	906	23	10	int:EWSR1
Interaction	CELF1 interactions	CPSF6 PRRC2A RBMX HNRNPK HNRNPL YLPM1 HNRNPR	2.28e-08	288	23	7	int:CELF1
Interaction	SFPQ interactions	SMARCD1 CPSF6 PRRC2A RBMX HNRNPK HNRNPL YLPM1 HNRNPR	1.20e-07	563	23	8	int:SFPQ
Interaction	CMTR1 interactions	CPSF6 TCF4 RBMX HNRNPK HNRNPL HNRNPR	1.29e-07	218	23	6	int:CMTR1
Interaction	KHDRBS1 interactions	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR MIA2	1.34e-07	373	23	7	int:KHDRBS1
Interaction	WWP2 interactions	SMARCD1 CPSF6 PRRC2A SEC24D RBMX HNRNPK HNRNPL YLPM1 HNRNPR	1.76e-07	840	23	9	int:WWP2
Interaction	RBMX interactions	CPSF6 PRRC2A RBMX HNRNPK HNRNPL YLPM1 HNRNPR	5.59e-07	461	23	7	int:RBMX
Interaction	ITSN2 interactions	WIPF2 CPSF6 RBMX HNRNPK YLPM1	5.84e-07	147	23	5	int:ITSN2
Interaction	FUS interactions	SMARCD1 CPSF6 PRRC2A RBMX HNRNPK HNRNPL YLPM1 HNRNPR	1.13e-06	757	23	8	int:FUS
Interaction	RBM42 interactions	CPSF6 PRRC2A HNRNPK HNRNPL YLPM1 HNRNPR	1.50e-06	331	23	6	int:RBM42
Interaction	DUSP14 interactions	SMARCD1 CPSF6 RBMX HNRNPK HNRNPL	1.63e-06	181	23	5	int:DUSP14
Interaction	MIR92A1 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	1.74e-06	78	23	4	int:MIR92A1
Interaction	PCDHB14 interactions	RBMX HNRNPK HNRNPR	1.97e-06	22	23	3	int:PCDHB14
Interaction	MIR10B interactions	CPSF6 HNRNPK HNRNPL HNRNPR	2.13e-06	82	23	4	int:MIR10B
Interaction	MIR199A1 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	2.34e-06	84	23	4	int:MIR199A1
Interaction	MIR17 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	2.45e-06	85	23	4	int:MIR17
Interaction	MIR18B interactions	CPSF6 HNRNPK HNRNPL HNRNPR	2.45e-06	85	23	4	int:MIR18B
Interaction	MIR93 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	2.45e-06	85	23	4	int:MIR93
Interaction	HNRNPDL interactions	WIPF2 CPSF6 RBMX HNRNPK HNRNPL HNRNPR	2.59e-06	364	23	6	int:HNRNPDL
Interaction	MIR29A interactions	CPSF6 HNRNPK HNRNPL HNRNPR	2.69e-06	87	23	4	int:MIR29A
Interaction	MIR138-2 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	2.82e-06	88	23	4	int:MIR138-2
Interaction	MIR155 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	3.37e-06	92	23	4	int:MIR155
Interaction	MIR128-1 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	3.37e-06	92	23	4	int:MIR128-1
Interaction	XRN2 interactions	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	3.38e-06	381	23	6	int:XRN2
Interaction	MIR19B2 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	3.67e-06	94	23	4	int:MIR19B2
Interaction	MIRLET7C interactions	CPSF6 HNRNPK HNRNPL HNRNPR	4.16e-06	97	23	4	int:MIRLET7C
Interaction	MIRLET7F2 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	4.16e-06	97	23	4	int:MIRLET7F2
Interaction	MIR128-2 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	4.52e-06	99	23	4	int:MIR128-2
Interaction	HNRNPC interactions	SMARCD1 CPSF6 TCF4 RBMX HNRNPK HNRNPL HNRNPR	4.66e-06	634	23	7	int:HNRNPC
Interaction	MIR19A interactions	CPSF6 HNRNPK HNRNPL HNRNPR	4.70e-06	100	23	4	int:MIR19A
Interaction	MIRLET7B interactions	CPSF6 HNRNPK HNRNPL HNRNPR	4.89e-06	101	23	4	int:MIRLET7B
Interaction	MIRLET7D interactions	CPSF6 HNRNPK HNRNPL HNRNPR	4.89e-06	101	23	4	int:MIRLET7D
Interaction	MIR25 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	4.89e-06	101	23	4	int:MIR25
Interaction	MIR19B1 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	5.49e-06	104	23	4	int:MIR19B1
Interaction	MIR34A interactions	CPSF6 HNRNPK HNRNPL HNRNPR	5.49e-06	104	23	4	int:MIR34A
Interaction	RPH3AL interactions	HNRNPK HNRNPL MYO15B	6.30e-06	32	23	3	int:RPH3AL
Interaction	MIRLET7A1 interactions	CPSF6 HNRNPK HNRNPL HNRNPR	6.38e-06	108	23	4	int:MIRLET7A1
Interaction	DDX17 interactions	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	6.41e-06	426	23	6	int:DDX17
Interaction	TLE5 interactions	SMARCD1 TCF4 HNRNPK HNRNPL MYO15B MIA2	8.01e-06	443	23	6	int:TLE5
Interaction	AR interactions	SMARCD1 CPSF6 TCF4 SSBP2 HNRNPL YLPM1 HNRNPR BCL9	8.47e-06	992	23	8	int:AR
Interaction	SCARNA22 interactions	RBMX HNRNPK HNRNPL HNRNPR	9.07e-06	118	23	4	int:SCARNA22
Interaction	TRIM31 interactions	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	9.22e-06	454	23	6	int:TRIM31
Interaction	MYCN interactions	SMARCD1 CPSF6 PRRC2A TCF4 SEC24D RBMX HNRNPK HNRNPL HNRNPR	1.05e-05	1373	23	9	int:MYCN
Interaction	KHDRBS2 interactions	RBMX HNRNPK HNRNPL HNRNPR	1.29e-05	129	23	4	int:KHDRBS2
Interaction	EIF4A3 interactions	WIPF2 CPSF6 RBMX HNRNPK HNRNPL HNRNPR	1.58e-05	499	23	6	int:EIF4A3
Interaction	PSPC1 interactions	WIPF2 CPSF6 PRRC2A HNRNPL YLPM1 HNRNPR	1.89e-05	515	23	6	int:PSPC1
Interaction	SNRPB interactions	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	1.93e-05	517	23	6	int:SNRPB
Interaction	TP63 interactions	CPSF6 TCF4 HNRNPK HNRNPL HNRNPR	2.03e-05	304	23	5	int:TP63
Interaction	DAZL interactions	CPSF6 PRRC2A HNRNPL HNRNPR	2.05e-05	145	23	4	int:DAZL
Interaction	CPSF6 interactions	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	2.12e-05	526	23	6	int:CPSF6
Interaction	PKNOX2 interactions	SMARCD1 HNRNPL MYO15B	2.17e-05	48	23	3	int:PKNOX2
Interaction	SMG7 interactions	CPSF6 PRRC2A HNRNPL YLPM1 BCL9	2.56e-05	319	23	5	int:SMG7
Interaction	IKZF3 interactions	SMARCD1 RBMX HNRNPK HNRNPL MYO15B	2.60e-05	320	23	5	int:IKZF3
Interaction	GLDC interactions	PRRC2A CREG2 HNRNPK HNRNPL HNRNPR	2.64e-05	321	23	5	int:GLDC
Interaction	RBM14 interactions	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	2.82e-05	553	23	6	int:RBM14
Interaction	LMO4 interactions	TCF4 SEC24D SSBP2 BCL9	2.94e-05	159	23	4	int:LMO4
Interaction	RBM3 interactions	RBMX HNRNPK YLPM1 HNRNPR	3.24e-05	163	23	4	int:RBM3
Interaction	CDC5L interactions	SMARCD1 CPSF6 RBMX HNRNPK MYO15B YLPM1 HNRNPR	3.26e-05	855	23	7	int:CDC5L
Interaction	DDX5 interactions	CPSF6 TCF4 RBMX HNRNPK HNRNPL HNRNPR	3.27e-05	568	23	6	int:DDX5
Interaction	LHX4 interactions	SMARCD1 TCF4 SSBP2 BCL9	3.48e-05	166	23	4	int:LHX4
Interaction	HNRNPA0 interactions	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	3.94e-05	349	23	5	int:HNRNPA0
Interaction	SSBP4 interactions	SSBP2 MYO15B BCL9	4.05e-05	59	23	3	int:SSBP4
Interaction	RALY interactions	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	4.33e-05	356	23	5	int:RALY
Interaction	CEBPA interactions	SMARCD1 CPSF6 PRRC2A RBMX HNRNPK HNRNPL HNRNPR BCL9	4.41e-05	1245	23	8	int:CEBPA
Interaction	IVNS1ABP interactions	RBMX HNRNPK HNRNPL HNRNPR	4.77e-05	180	23	4	int:IVNS1ABP
Interaction	ALG13 interactions	CPSF6 PRRC2A HNRNPR BCL9	5.09e-05	183	23	4	int:ALG13
Interaction	PRMT1 interactions	CPSF6 PRRC2A RBMX HNRNPK HNRNPL YLPM1 HNRNPR	5.54e-05	929	23	7	int:PRMT1
Interaction	ATP11B interactions	TCF4 HNRNPL	5.58e-05	10	23	2	int:ATP11B
Interaction	MECP2 interactions	SMARCD1 CPSF6 SSBP2 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	5.59e-05	1287	23	8	int:MECP2
Interaction	HNRNPA1 interactions	CPSF6 PRRC2A RBMX HNRNPK HNRNPL YLPM1 HNRNPR	6.17e-05	945	23	7	int:HNRNPA1
Interaction	MIR138-1 interactions	HNRNPK HNRNPL HNRNPR	6.20e-05	68	23	3	int:MIR138-1
Interaction	HNRNPD interactions	CPSF6 RBMX HNRNPK HNRNPL YLPM1 HNRNPR	6.26e-05	638	23	6	int:HNRNPD
Interaction	OGT interactions	SMARCD1 CPSF6 TCF4 RBMX HNRNPK HNRNPL HNRNPR	6.38e-05	950	23	7	int:OGT
Interaction	TNIP2 interactions	SMARCD1 CPSF6 PRRC2A RBMX HNRNPL YLPM1 HNRNPR	6.47e-05	952	23	7	int:TNIP2
Interaction	APBB1 interactions	WIPF2 CPSF6 HNRNPK YLPM1	6.52e-05	195	23	4	int:APBB1
Interaction	MIR9-3 interactions	HNRNPK HNRNPL HNRNPR	6.76e-05	70	23	3	int:MIR9-3
Interaction	MIR140 interactions	HNRNPK HNRNPL HNRNPR	7.05e-05	71	23	3	int:MIR140
Interaction	MIR122 interactions	HNRNPK HNRNPL HNRNPR	7.05e-05	71	23	3	int:MIR122
Interaction	MIR29B2 interactions	HNRNPK HNRNPL HNRNPR	7.05e-05	71	23	3	int:MIR29B2
Interaction	SORBS3 interactions	WIPF2 RBMX HNRNPK MYO15B	7.47e-05	202	23	4	int:SORBS3
Interaction	MIR18A interactions	HNRNPK HNRNPL HNRNPR	7.67e-05	73	23	3	int:MIR18A
Interaction	MIR29B1 interactions	HNRNPK HNRNPL HNRNPR	7.67e-05	73	23	3	int:MIR29B1
Interaction	MIR20A interactions	HNRNPK HNRNPL HNRNPR	7.98e-05	74	23	3	int:MIR20A
Interaction	TCF23 interactions	TCF4 HNRNPK	8.17e-05	12	23	2	int:TCF23
Interaction	RBM45 interactions	RBMX HNRNPK HNRNPL HNRNPR	8.21e-05	207	23	4	int:RBM45
Interaction	TAF15 interactions	CPSF6 RBMX HNRNPK HNRNPL HNRNPR	8.26e-05	408	23	5	int:TAF15
Interaction	MIR15A interactions	HNRNPK HNRNPL HNRNPR	8.31e-05	75	23	3	int:MIR15A
Interaction	MIR7-3 interactions	HNRNPK HNRNPL HNRNPR	8.65e-05	76	23	3	int:MIR7-3
Interaction	MIR16-1 interactions	HNRNPK HNRNPL HNRNPR	8.65e-05	76	23	3	int:MIR16-1
Interaction	MIR199A2 interactions	HNRNPK HNRNPL HNRNPR	8.65e-05	76	23	3	int:MIR199A2
Interaction	MIR429 interactions	HNRNPK HNRNPL HNRNPR	8.65e-05	76	23	3	int:MIR429
Interaction	RC3H1 interactions	CPSF6 PRRC2A RBMX HNRNPK HNRNPL HNRNPR	8.70e-05	677	23	6	int:RC3H1
Interaction	SMC5 interactions	CPSF6 PRRC2A RBMX HNRNPK HNRNPL YLPM1 HNRNPR	8.82e-05	1000	23	7	int:SMC5
Interaction	MIR9-2 interactions	HNRNPK HNRNPL HNRNPR	8.99e-05	77	23	3	int:MIR9-2
Interaction	MIR200A interactions	HNRNPK HNRNPL HNRNPR	8.99e-05	77	23	3	int:MIR200A
Interaction	NR4A1 interactions	SMARCD1 TCF4 HNRNPL HNRNPR	9.01e-05	212	23	4	int:NR4A1
Interaction	SSRP1 interactions	PRRC2A RBMX HNRNPK HNRNPL YLPM1 HNRNPR	9.28e-05	685	23	6	int:SSRP1
Interaction	MIR98 interactions	HNRNPK HNRNPL HNRNPR	9.34e-05	78	23	3	int:MIR98
GeneFamily	RNA binding motif containing	CPSF6 RBMX HNRNPL HNRNPR	1.23e-05	213	13	4	725
GeneFamily	Basic helix-loop-helix proteins	TCF4 BHLHA9	2.74e-03	110	13	2	420
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 RBMX HNRNPK HNRNPR	6.39e-08	199	24	5	ea75804c34989c99aab542e6d72617ed144819b6
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 RBMX HNRNPK HNRNPR	6.39e-08	199	24	5	fe3b7d540a644dfc6beea171c809b4d1ba4e188f
ToppCell	10x5'v1-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 RBMX HNRNPK HNRNPR	6.39e-08	199	24	5	713dfd8552635645db5e0b5721c64e5c9b4aa06c
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 RBMX HNRNPK HNRNPR	6.39e-08	199	24	5	cdee798e3586e4e7a15de598239090a85752ea1e
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 RBMX HNRNPK	3.06e-06	190	24	4	f623f0bdece6002b68ac2207e99408b24a2b1194
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SSBP2 RBMX HNRNPK HNRNPR	3.47e-06	196	24	4	6ba02b806d440eed45bad7616bf3b8be57034427
ToppCell	10x5'v1-week_14-16-Lymphocytic_B\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 HNRNPK HNRNPR	3.54e-06	197	24	4	31dfd9842410b5c629f39b5130233995dceb0aef
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 HNRNPK HNRNPR	3.54e-06	197	24	4	7290f05d0b8465637420119941bcbf2fae44a7e4
ToppCell	facs-Trachea-3m\|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TCF4 SEC24D HNRNPK HNRNPL	3.54e-06	197	24	4	e77016d64b1cac9825fec7cfe5071f1567401187
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SSBP2 RBMX HNRNPK HNRNPR	3.54e-06	197	24	4	106b0f9a0425facc634feb7498c9ba2c55edfbf8
ToppCell	facs-Trachea-nan-3m\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF4 SEC24D HNRNPK HNRNPL	3.54e-06	197	24	4	0353d925ee4b7aefc2c51b5fab873f465cdf9ebc
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 HNRNPK HNRNPR	3.61e-06	198	24	4	8aa4149d2c1cec73cfd654db093252ec8ec5ef68
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TCF4 RBMX HNRNPK HNRNPR	3.61e-06	198	24	4	cd876fba12ff30b74aa507286cb1f3a867011a92
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RBMX HNRNPK HNRNPL HNRNPR	3.61e-06	198	24	4	a07307ecc3d86fbcaf7369b7fce60334b7e2dc8f
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 HNRNPK HNRNPR	3.68e-06	199	24	4	5478b78349b5d8d57f30bb650dcbd5fdb84283d6
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 HNRNPK HNRNPR	3.68e-06	199	24	4	8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SSBP2 RBMX HNRNPK HNRNPR	3.68e-06	199	24	4	be425e9cb90a73289026b1b7cb581e1c02a8985e
ToppCell	10x5'v1-week_17-19-Lymphocytic_B\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SSBP2 RBMX HNRNPK HNRNPR	3.76e-06	200	24	4	364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 HNRNPK HNRNPR	3.76e-06	200	24	4	19a4213f180ac2d29625d140b602a93a74ab3fdd
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 HNRNPK HNRNPR	3.76e-06	200	24	4	0fd9a8730b7dc461ddf4586899d363541e72d8ba
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SSBP2 RBMX HNRNPK HNRNPR	3.76e-06	200	24	4	c28d4ca51d2e2a3a22784ee251975f16a55b0297
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RBMX HNRNPK HNRNPR	1.05e-04	172	24	3	7f3d0ef18f5df1ed80498d435b0378ca398c0b88
ToppCell	droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDIP1 TCF4 SEC24D	1.12e-04	176	24	3	d4075796c38b775fe721abb47426e662a0d415e3
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CREG2 RBMX YLPM1	1.14e-04	177	24	3	9edfb50856f5e10672ab194ce0076d6a190e64de
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Late_pro-B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TCF4 SSBP2 CREG2	1.16e-04	178	24	3	4e28a8bd5a603518bfe993712ab785308691b5ff
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDIP1 TCF4 SEC24D	1.18e-04	179	24	3	1757b9f3f4c634277a67c4f5a39d27d6b4937073
ToppCell	droplet-Spleen-nan-24m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDIP1 TCF4 SEC24D	1.18e-04	179	24	3	d50d29f26d5a2cd8c4cd4e1244e1bb8de072d159
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5\|Hippocampus / BrainAtlas - Mouse McCarroll V32	RBMX HNRNPK HNRNPR	1.20e-04	180	24	3	44988c34861df359a68376500c42a64fbcc4b431
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDIP1 TCF4 SEC24D	1.20e-04	180	24	3	64f01494a4052186773720e10b4e7c724ff94547
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDIP1 TCF4 SEC24D	1.24e-04	182	24	3	33afbb7c4352b03266501b1f4f0e751c12c7350d
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZIC4 TCF4 CREG2	1.28e-04	184	24	3	1da7936a2616986efd5de601ad525f1f2355128a
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CDIP1 TCF4 SEC24D	1.30e-04	185	24	3	65dcb0a7ee64990a34a87c167b44497107f035ee
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANGPTL1 TCF4 SSBP2	1.36e-04	188	24	3	d8decd9b5967873ca8320c2f9f07365f163c777f
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE\|Hippocampus / BrainAtlas - Mouse McCarroll V32	RBMX HNRNPK HNRNPR	1.36e-04	188	24	3	8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc
ToppCell	droplet-Thymus-nan-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSBP2 RBMX HNRNPK	1.47e-04	193	24	3	81871f4f2b63ca5f64a9ff12f6c909a34bf52216
ToppCell	droplet-Thymus-nan-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSBP2 RBMX HNRNPK	1.47e-04	193	24	3	12380713db6582749183a19de65d4af9d6469a3f
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 HNRNPK	1.49e-04	194	24	3	f64da5f62e29253d60b9546edf734ba5c17daae1
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SMARCD1 TCF4 RBMX	1.54e-04	196	24	3	fd756b247b2d8a291e8e71bec6f1e463d6557536
ToppCell	droplet-Thymus-nan-21m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SSBP2 RBMX HNRNPK	1.54e-04	196	24	3	313d66313d7c93d9ae4c8b790262ba7a85b34fe4
ToppCell	10x_3'_v3\|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HNRNPK HNRNPL HNRNPR	1.59e-04	198	24	3	aabb8e9b162ae4cb26ea860c99decdbb51e379e1
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HNRNPK HNRNPL HNRNPR	1.59e-04	198	24	3	039b67ddd0ac529453a364552abca04e67d8417c
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TCF4 SSBP2 HNRNPR	1.61e-04	199	24	3	8daf945fc93169b0a4fa3ef9f4a87eedd52e314a
ToppCell	facs-Trachea-nan-3m-Mesenchymal\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANGPTL1 TCF4 SEC24D	1.61e-04	199	24	3	67f78c070c56e44fba36542041bf7fa1c291807c
ToppCell	facs-Trachea-nan-3m-Mesenchymal-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANGPTL1 TCF4 SEC24D	1.61e-04	199	24	3	1ae244b563f85c1ee8d22698f478c842a4d9c7f5
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	WIPF2 SMARCD1 HNRNPL	1.63e-04	200	24	3	ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc
ToppCell	TCGA-Bile_Duct-Primary_Tumor\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	WIPF2 SMARCD1 HNRNPL	1.63e-04	200	24	3	0350e5ffd36033099b7e32a1fdd790fff99790dc
Computational	Neighborhood of TDG	CPSF6 RBMX HNRNPK HNRNPR	2.79e-07	35	18	4	GNF2_TDG
Computational	Neighborhood of ELAC2	CPSF6 RBMX HNRNPK HNRNPR	8.60e-07	46	18	4	GNF2_ELAC2
Computational	Neighborhood of DENR	CPSF6 MAPK1IP1L RBMX HNRNPR	1.31e-06	51	18	4	GNF2_DENR
Computational	Neighborhood of KPNB1	CPSF6 RBMX HNRNPK HNRNPR	5.57e-06	73	18	4	GNF2_KPNB1
Computational	Neighborhood of DAP3	CPSF6 MAPK1IP1L RBMX HNRNPR	3.88e-05	119	18	4	GNF2_DAP3
Computational	Neighborhood of DEK	CPSF6 RBMX HNRNPR	1.15e-04	58	18	3	GNF2_DEK
Computational	Neighborhood of NPM1	CPSF6 RBMX HNRNPR	2.19e-04	72	18	3	GNF2_NPM1
Computational	Neighborhood of XRCC5	CPSF6 RBMX HNRNPK	2.47e-04	75	18	3	GNF2_XRCC5
Computational	Neighborhood of APEX1	CPSF6 RBMX HNRNPR	4.51e-04	92	18	3	GNF2_APEX1
Computational	Neighborhood of HDAC1	RBMX HNRNPK HNRNPR	7.61e-04	110	18	3	GNF2_HDAC1
Computational	Neighborhood of SMC1L1	RBMX HNRNPK	9.07e-04	27	18	2	GNF2_SMC1L1
Computational	Neighborhood of RPA1	RBMX HNRNPK	9.76e-04	28	18	2	GNF2_RPA1
Computational	Neighborhood of FBL	CPSF6 RBMX HNRNPR	1.72e-03	146	18	3	GNF2_FBL
Computational	Neighborhood of CDC10	HNRNPK HNRNPL HNRNPR	1.72e-03	146	18	3	MORF_CDC10
Computational	Neighborhood of PPP6C	MAPK1IP1L HNRNPK	1.89e-03	39	18	2	GNF2_PPP6C
Computational	Neighborhood of VAV1	SMARCD1 HNRNPL	2.74e-03	47	18	2	GCM_VAV1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	TCF4 SSBP2	3.09e-03	50	18	2	GAVISH_3CA_METAPROGRAM_B_CELLS_PROGENITOR
Computational	Neighborhood of MCM5	CPSF6 RBMX	4.57e-03	61	18	2	GNF2_MCM5
Computational	Neighborhood of SMC1L1	RBMX HNRNPR	4.72e-03	62	18	2	MORF_SMC1L1
Computational	Neighborhood of ATRX	WIPF2 HNRNPL MIA2	5.16e-03	215	18	3	MORF_ATRX
Computational	Neighborhood of TERF1	HNRNPK HNRNPR	5.49e-03	67	18	2	MORF_TERF1
Computational	Genes in the cancer module 493.	TCF4 SSBP2	5.81e-03	69	18	2	MODULE_493
Computational	Genes in the cancer module 32.	RBMX HNRNPL HNRNPR	7.08e-03	241	18	3	MODULE_32
Drug	Pyrazinamide [ 98-96-4]; Down 200; 32.4uM; MCF7; HT_HG-U133A	WIPF2 SMARCD1 PRRC2A MIA2 BCL9	1.40e-06	198	23	5	2839_DN
Drug	AC1L1AUZ	RBMX HNRNPK HNRNPL HNRNPR	1.74e-05	157	23	4	CID000001160
Drug	AC1NRA5C	RBMX HNRNPK HNRNPL HNRNPR	2.60e-05	174	23	4	CID005287709
Drug	Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A	WIPF2 TCF4 YLPM1 BCL9	4.23e-05	197	23	4	5819_DN
Drug	N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA	SMARCD1 PRRC2A SEC24D YLPM1	4.23e-05	197	23	4	959_UP
Drug	pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A	ZIC4 SSBP2 MIA2 ASIC3	4.32e-05	198	23	4	7506_DN
Disease	Malignant neoplasm of breast	SMARCD1 PRRC2A HNRNPK HNRNPL HNRNPR MIA2	1.36e-04	1074	23	6	C0006142
Disease	irritable bowel syndrome	PRRC2A TCF4 YLPM1	1.42e-04	131	23	3	EFO_0000555
Disease	Breast Carcinoma	SMARCD1 HNRNPK HNRNPL HNRNPR	7.35e-04	538	23	4	C0678222
Disease	coffee consumption measurement, neuroticism measurement	TCF4 YLPM1	1.25e-03	67	23	2	EFO_0006781, EFO_0007660
Disease	feeling "fed-up" measurement	TCF4 YLPM1	1.60e-03	76	23	2	EFO_0009588
Disease	Psychotic Disorders	TCF4 BCL9	2.80e-03	101	23	2	C0033975
Disease	cortical surface area measurement	ZIC4 CPSF6 PRRC2A TCF4 SSBP2	3.31e-03	1345	23	5	EFO_0010736
Disease	Polydactyly	HNRNPK BHLHA9	3.73e-03	117	23	2	C0152427
Disease	age at first birth measurement	PRRC2A TCF4	3.92e-03	120	23	2	EFO_0009101
Disease	mood instability measurement	TCF4 YLPM1	4.45e-03	128	23	2	EFO_0008475
Disease	Global developmental delay	SMARCD1 HNRNPR	4.79e-03	133	23	2	C0557874
Disease	unipolar depression, mood disorder	TCF4 YLPM1	4.87e-03	134	23	2	EFO_0003761, EFO_0004247
Disease	Intellectual Disability	SMARCD1 HNRNPK HNRNPR	4.88e-03	447	23	3	C3714756
Disease	Bipolar Disorder	TCF4 SSBP2 BCL9	5.85e-03	477	23	3	C0005586
Disease	photoreceptor cell layer thickness measurement	TCF4 YLPM1	5.90e-03	148	23	2	EFO_0803370
Disease	Mammary Neoplasms, Human	HNRNPK HNRNPL HNRNPR	7.61e-03	525	23	3	C1257931
Disease	Mammary Carcinoma, Human	HNRNPK HNRNPL HNRNPR	7.61e-03	525	23	3	C4704874
Disease	risky sexual behaviour measurement	ZIC4 TCF4	7.62e-03	169	23	2	EFO_0007877
Disease	Mammary Neoplasms	HNRNPK HNRNPL HNRNPR	7.69e-03	527	23	3	C1458155
Disease	health study participation	PRRC2A TCF4	1.00e-02	195	23	2	EFO_0010130
Disease	cortical thickness	ZIC4 CPSF6 TCF4 YLPM1	1.01e-02	1113	23	4	EFO_0004840
Disease	pain	CPSF6 TCF4	1.01e-02	196	23	2	EFO_0003843

Protein segments in the cluster

Peptide	Gene	Start	Entry
GMPLPPADIGPPPYE	CDIP1	41	Q9H305
PPPWPRGYLRSAPGM	BHLHA9	216	Q7RTU4
RDPGYPRDLMPPPDL	ANGPTL1	241	O95841
PPPAPPGMFSYRREG	CREG2	96	Q8IUH2
ERGLPPSMERGYPPP	RBMX	346	P38159
DLNPPQDPYRGMPPG	TCF4	486	P15884
YHPPPRMPPPIRGRG	HNRNPR	436	O43390
LRALGRPPAPPGFMP	ASIC3	126	Q9UHC3
QPPEYPGRPDMAVPG	MYO15B	86	Q96JP2
RPPPYDRGDYGPPGR	CPSF6	386	Q16630
GPRGVVRGPPPPYQM	BCL9	506	O00512
EGYGPPPPHYEGRRM	HNRNPL	331	P14866
PPPHYEGRRMGPPVG	HNRNPL	336	P14866
GDFPGPPPAPFAMRN	MIA2	1346	Q96PC5
MPFPELPRPYGAPTD	MAPK1IP1L	121	Q8NDC0
FMSPRYPGGPRPPLR	SSBP2	126	P81877
PPVRMGPAPGQGLYR	SMARCD1	36	Q96GM5
PPPPPRGGDLMAYDR	HNRNPK	311	P61978
GMAVPADPPPASPYR	PRORY	86	Q9H606
KALYPGALGRPPPMP	PRRC2A	701	P48634
PGASPLPLPMYRPDG	SEC24D	181	O94855
LPLPMYRPDGLSGPP	SEC24D	186	O94855
SRPGMYPPPGSYRPP	YLPM1	1501	P49750
GLPGDMYARPEPFPP	ZIC4	66	Q8N9L1
MYARPEPFPPGPAAR	ZIC4	71	Q8N9L1
ARDAPPPPPPYRMHG	WIPF2	336	Q8TF74
MYPAGPPAGPVPRRG	TIGD5	1	Q53EQ6